COVID-FIS: A Phase 2 Placebo-Controlled Pilot Study in COVID-19 of Fisetin to Alleviate Dysfunction and Excessive Inflammatory Response in Older Adults in Nursing Homes
Phase: PHASE2
Conditions: Covid19, SARS-CoV Infection
Sponsor: Mayo Clinic

 
 
COVID-FIS: A PHASE 2 PLACEBO-CONTROLLED 
PILOT STUDY IN COVID-19 OF FISETIN TO 
ALLEVIATE DYSFUNCTION AND EXCESSIVE 
INFLAMMATORY RESPONSE IN OLDER ADULTS 
IN NURSING HOMES 
 
NCT04537299 
 
26May2023